40
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV 1

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Fungal sensitization is common in severe asthma, but the clinical relevance of this and the relationship with airway colonization by fungi remain unclear. The range of fungi that may colonize the airways in asthma is unknown.

          Objective

          To provide a comprehensive analysis on the range of filamentous fungi isolated in sputum from people with asthma and report the relationship with their clinico-immunological features of their disease.

          Methods

          We recruited 126 subjects with a diagnosis of asthma, 94% with moderate-severe disease, and 18 healthy volunteers. At a single stable visit, subjects underwent spirometry; sputum fungal culture and a sputum cell differential count; skin prick testing to both common aeroallergens and an extended fungal panel; specific IgE to Aspergillus fumigatus. Fungi were identified by morphology and species identity was confirmed by sequencing. Four patients had allergic bronchopulmonary aspergillosis.

          Results

          Forty-eight percent of asthma subjects were IgE-sensitized to one fungal allergen and 22% to ≥ 2. Twenty-seven different taxa of filamentous fungi were isolated from 54% of their sputa, more than one species being detected in 17%. This compared with 3 (17%) healthy controls culturing any fungus ( P < 0.01). Aspergillus species were most frequently cultured in isolation followed by Penicillium species. Post-bronchodilator FEV 1 (% predicted) in the subjects with asthma was 71(± 25) in those with a positive fungal culture vs. 83 (± 25) in those culture-negative, ( P < 0.01).

          Conclusion and Clinical Relevance

          Numerous thermotolerant fungi other than A. fumigatus can be cultured from sputum of people with moderate-to-severe asthma; a positive culture is associated with an impaired post-bronchodilator FEV 1, which might be partly responsible for the development of fixed airflow obstruction in asthma. Sensitization to these fungi is also common.

          Related collections

          Most cited references47

          • Record: found
          • Abstract: not found
          • Book Chapter: not found

          AMPLIFICATION AND DIRECT SEQUENCING OF FUNGAL RIBOSOMAL RNA GENES FOR PHYLOGENETICS

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The link between fungi and severe asthma: a summary of the evidence.

            There is current evidence to demonstrate a close association between fungal sensitisation and asthma severity. Whether such an association is causal remains to be confirmed, but this is explored by means of a detailed literature review. There is evidence from two randomised controlled trials that, in the example of allergic bronchopulmonary aspergillosis (ABPA), treatment with systemic antifungal therapy can offer a therapeutic benefit to approximately 60% of patients. ABPA is only diagnosed if a combination of clinical and immunological criteria is achieved. It is not known whether such cases are a discrete clinical entity or part of a spectrum of the pulmonary allergic response to fungi or fungal products. This paper describes the epidemiological evidence that associates severity of asthma with fungi and discusses possible pathogenetic mechanisms. Many airborne fungi are involved, including species of Alternaria, Aspergillus, Cladosporium and Penicillium, and exposure may be indoors, outdoors or both. The potential for a therapeutic role of antifungal agents for patients with severe asthma and fungal sensitisation is also explored. Not only are many patients with severe asthma desperately disabled by their disease, but, in the UK alone, asthma accounts for 1,500 deaths per yr. The healthcare costs of these patients are enormous and any treatment option merits close scrutiny. Within this report, the case for the consideration of a new term related to this association is put forward. The current authors propose the term "severe asthma with fungal sensitisation". However, it is recognised that enhanced and precise definition of fungal sensitisation will require improvements in diagnostic testing.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Glucocorticoids and invasive fungal infections.

              Since the 1990s, opportunistic fungal infections have emerged as a substantial cause of morbidity and mortality in profoundly immunocompromised patients. Hypercortisolaemic patients, both those with endogenous Cushing's syndrome and, much more frequently, those receiving exogenous glucocorticoid therapy, are especially at risk of such infections. This vulnerability is attributed to the complex dysregulation of immunity caused by glucocorticoids. We critically review the spectrum and presentation of invasive fungal infections that arise in the setting of hypercortisolism, and the ways in which glucocorticoids contribute to their pathogenesis. A better knowledge of the interplay between glucocorticoid-induced immunosuppression and invasive fungal infections should assist in earlier recognition and treatment of such infections. Efforts to decrease the intensity of glucocorticoid therapy should help to improve outcomes of opportunistic fungal infections.
                Bookmark

                Author and article information

                Journal
                Clin Exp Allergy
                Clin. Exp. Allergy
                cea
                Clinical and Experimental Allergy
                Blackwell Publishing Ltd
                0954-7894
                1365-2222
                May 2012
                20 April 2012
                : 42
                : 5
                : 782-791
                Affiliations
                [1 ]Department of Infection, Immunity and Inflammation, Institute for Lung Health, University of Leicester Leicester, UK
                [2 ]Department of Respiratory Medicine, Glenfield Hospital Leicester, UK
                Author notes
                Prof Andrew J. Wardlaw, Institute for Lung Health, Department of Infection, Immunity and Inflammation, Glenfield Hospital, Groby Road, Leicester LE3 9QP, UK. E-mail: Aw24@ 123456le.ac.uk
                [*]

                Joint first authors.

                Re-use of this article is permitted in accordance with the Terms and Conditions set out at http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms

                Article
                10.1111/j.1365-2222.2012.03987.x
                3509218
                22515394
                ab569aa9-a441-4a12-a3c6-7b76ae425e0d
                Copyright © 2012 Blackwell Publishing Ltd

                Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.

                History
                : 01 July 2011
                : 20 January 2012
                : 23 January 2012
                Categories
                Original Articles

                Immunology
                fungal allergy,fungal culture,asthma,airflow obstruction
                Immunology
                fungal allergy, fungal culture, asthma, airflow obstruction

                Comments

                Comment on this article